Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

MK-2866 and MK-677 Interaction: Synergistic | Peptide Database

Can you take MK-2866 with MK-677? Synergistic interaction (95% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

MK-2866

Selective Androgen Receptor Modulator | Muscle Wasting Research

MK-2866 binds to the androgen receptor (AR) with high affinity and selectivity, functioning as a partial agonist in muscle and bone tissue. Upon binding, the MK-2866-AR complex undergoes a conformational change that promotes nuclear translocation and interaction with androgen response elements (AREs) on DNA, activating transcription of genes involved in protein synthesis, nitrogen retention, and myogenic differentiation.

MK-677

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take MK-2866 with MK-677?

Yes, MK-2866 and MK-677 can generally be taken together. MK-677 (Ibutamoren) stimulates growth hormone secretion through ghrelin receptor agonism, while MK-2866 provides direct androgen receptor activation in muscle. The combination supports lean mass accrual through complementary mechanisms without additive HPTA suppression, as MK-677 does not affect the androgen axis. Commonly stacked for body recomposition and lean gain goals.

Is MK-2866 and MK-677 safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, hepatotoxic. Monitor accordingly.

What are the interactions between MK-2866 and MK-677?

MK-677 (Ibutamoren) stimulates growth hormone secretion through ghrelin receptor agonism, while MK-2866 provides direct androgen receptor activation in muscle. The combination supports lean mass accrual through complementary mechanisms without additive HPTA suppression, as MK-677 does not affect the androgen axis. Commonly stacked for body recomposition and lean gain goals. This assessment has 95% confidence and is based on documented research data.

How should I time MK-2866 and MK-677?

MK-2866 has a half-life of ~24 hours and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question